British Patient Capital
Tom manages the direct co-investment programme at British Patient Capital. Prior to joining British Patient Capital, he was an investor at Foresight Group and EcoMachines Ventures before that. Earlier in his career he co-founded a biotech manufacturing startup called Puridify that sold to GE Healthcare and worked in investment banking at Deutsche Bank. He holds an MBA from London Business School and is a CFA Charterholder.
Paola Bergamaschi Broyd
Frank VerkerkABN AMRO Ventures
Lord Jonathan Evans
You may also be interested in…
The #1 Data Secret to Replacing Your Legacy IT Systems
Digital transformation begins with replacing outdated, legacy IT systems. Learn how to replace IT applications without causing major disruption to your business.
Danske Bank Deploys Quantexa’s AI Platform For Financial Crime Detection
Danske Bank uses Quantexa’s platform to uncover the real-world context in data to detect financial crime and improve investigations.
How To Detect Insurance Fraud Threats [Infographic]
Throughout the pandemic, the threat of fraud
and scams has intensified as the global economy
continues to struggle and financial pressures grow. Find out how automated fraud detection can help insurers save from losses.
How Government Agencies Can Improve Fraud Prevention Using Analytics and Data
Government agencies using data-driven, analytical approaches to fraud prevention can discover risks and threats faster compared to traditional methods – a critical advantage that helps reduce fraud losses and increase the likelihood of recovering funds.
How To Detect Wash Trades and Market Manipulation
Financial criminals are using wash trades to move funds out of high-risk jurisdictions. With the right technology, you can uncover this hidden risk.
IDC Report: Maximize Your Decision Intelligence by Analyzing Contextual Data
By adopting best practices for AI and analytics, companies can enable data-driven decision intelligence to become more agile and competitive.